Troglitazone OverviewTroglitazone is an antidiabetic and anti-inflammatory drug, and a member of the drug class of the thiazolidinediones. It was prescribed for people with diabetes mellitus type 2. It was patented in 1983 and approved for medical use in 1997. It was subsequently withdrawn. Contents 1 Mechanism of action 2 History 3 Mechanisms of hepatotoxicity 4 Lawsuits 5 References 6 External links Mechanism of action Troglitazone, like the other thiazolidinedione...
Read more Troglitazone Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Troglitazone
Recent Troglitazone Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 200mg, 300mg, 400mg